Ambuja Cements stock
AMBUJACEM.NSNSEAmbuja Cements Limited, Basic MaterialsISIN INE079A01024
47Score 47 out of 100, Weak
Price and trend
57 / 100
Price history
−31% in one yearThe chart shows daily closes over 19 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 9.6% below it.
Since December 2025 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 66).
The price is 32% below its 52-week high. Largest decline in 19 years: 71% (December 2007 to October 2008).
Chart figures for advanced users
- SMA 50$3.98
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$4.58
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)66
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$3.62
- The lowest closing price of the last twelve months.
- Resistance$6.07
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Ambuja Cements Limited belongs to the Construction Materials industry (India) and, with a market value of $10.28B, is number 18 of 63 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $4.3B (up 21.2% year on year) and earnings of $502.55M (up 13.5%).
- For fiscal 2027, analysts expect on average revenue of $4.52B (up 5.1%) and adjusted earnings per share of $0.09 (down 54.4%).
Show more
- MEQIRI Score 47 out of 100 (Weak): rank 344 of 461 in Basic Materials, median 57.
- The P/E is 34.5 (Construction Materials median 27.6, own median of recent years 29.1).
- Our model puts fair value at $2.14, with the price 93% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 28.2% a year through 2029 (estimates from 32 analysts).
- Consistently profitableProfit in all 10 fiscal years from 2017 to 2026.Fundamentals 51
- More cash than debtCash $101.89M, financial debt $92.04M.Stability 82
Weaknesses
- Above fair valuePrice 93% above the fair value of $2.14.Valuation 41
- DilutionShare count up 24% since 2021.Capital allocation 24
- Margin fallingOperating margin 6.3%, average of the prior years 14.7% (to 2025).Profitability 45
Its standout strength is stability, while growth and capital allocation hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $1.53 and expensive above $3.57 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $0.97 (cash-flow model) and $3.32 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 13.5%. At 14.5% the fair value would be $2.05, at 12.5% it would be $2.28.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (27.6).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 6.4% on the twelve months before. Revenue has grown solidly since 2007, at about 10% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 46%, operating 6%, net 12%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 3 Feb 2027in 82 days
- Last reported
- 29 Oct 2026EPS reported $0.01 (expected $0.02)below expectations
Analyst estimates
Analysts have cut their 2028 earnings estimate by 10.9% since 27 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $0.09−10.5%
- Revenue
- $4.52B−1.6%
- Earnings per share
- $0.14−10.9%
- Revenue
- $5.02B−1.1%
MEQIRI has stored the estimates since 27 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Ambuja Cements
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 47
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Construction Materials
The next larger and next smaller companies by market value
- James Hardie IndustriesJHX $16.03B59
- CEMEX, S.A.B. de C.V.CX $15.19B57
- Carlisle CompaniesCSL $15.17B78
- Anhui Conch Cement600585.SS $14.18B48
- Shree CementSHREECEM.NS $9.67B52
- Advanced Drainage SystemsWMS $9.12B64
- Owens CorningOC $9.06B57
- BuzziBZU.MI $8.63B72
ETFs that hold Ambuja Cements
Held by 17 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares MSCI India UCITS ETFQDV5 | 0.18% | 0.65% | €4.98B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.03% | 0.17% | €5.24B |
| iShares MSCI EM Asia UCITS ETFCEBL | 0.03% | 0.20% | €7.14B |
Show 5 more
| iShares MSCI EM UCITS ETF USD (Acc)EUNM | 0.02% | 0.18% | €9.24B |
| Amundi Core MSCI Emerging Markets UCITS ETF EUR DistAEMD | 0.02% | 0.18% | €9.52B |
| iShares MSCI EM IMI Screened UCITS ETF USD (Acc)AYEM | 0.02% | 0.18% | €5.26B |
| iShares Core MSCI EM IMI UCITS ETFIS3N | 0.02% | 0.18% | €37.98B |
| Vanguard FTSE All-World UCITS ETF (USD) AccumulatingVWCE | 0.01% | 0.14% | €79.59B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 2 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.